Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jordan

Showing results (551-560 of 572) with videos related to

Pageof 58
Sort By:
Blood Advances|August 30, 2021
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRSHoward Lin, Brooks P Scull, Baruch R Goldberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 9, 2024
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review StudyShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast CancerMatthew P Humphries, Sreekumar Sundara Rajan, Alastair Droop, et al.
Science (New York, N.Y.)|July 25, 2015
AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapyBernice Lo, Kejian Zhang, Wei Lu, et al.
American Journal of Human Genetics|November 17, 2020
Multiplexed Functional Assessment of Genetic Variants in CARD11Iana Meitlis, Eric J Allenspach, Bradly M Bauman, et al.
Blood Advances|January 18, 2025
PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosisFiona Brown-Burke, Rachel Saadey, Hsiao-Yin Charlene Mao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
RMD Open|February 6, 2016
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Haematologica|May 30, 2015
The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesisSebastian Fn Bode, Sandra Ammann, Waleed Al-Herz, et al.
Pageof 58

Showing results (551-560 of 572) with videos related to

Sort By:
Pageof 58
Blood Advances|August 30, 2021
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRSHoward Lin, Brooks P Scull, Baruch R Goldberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 9, 2024
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review StudyShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast CancerMatthew P Humphries, Sreekumar Sundara Rajan, Alastair Droop, et al.
Science (New York, N.Y.)|July 25, 2015
AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapyBernice Lo, Kejian Zhang, Wei Lu, et al.
American Journal of Human Genetics|November 17, 2020
Multiplexed Functional Assessment of Genetic Variants in CARD11Iana Meitlis, Eric J Allenspach, Bradly M Bauman, et al.
Blood Advances|January 18, 2025
PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosisFiona Brown-Burke, Rachel Saadey, Hsiao-Yin Charlene Mao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
RMD Open|February 6, 2016
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Haematologica|May 30, 2015
The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesisSebastian Fn Bode, Sandra Ammann, Waleed Al-Herz, et al.
Pageof 58